- Bioactive constituents and action mechanism of Xiaoyao San for treatment of non-alcoholic fatty liver disease
- Browse: 213 Download: 557 Issue Date: 2024-10-21
- Calcineurin inhibitors-related posterior reversible encephalopathy syndrome in liver transplant recipients: Three case reports and review of literature
- Browse: 160 Download: 618 Issue Date: 2024-09-23
- Hepatic ectopic pregnancy with hemorrhage secondary diaphragmatic adhesion: A case report
- Browse: 183 Download: 600 Issue Date: 2024-09-23
- Immune remodulation in pediatric inherited metabolic liver diseases
- Browse: 174 Download: 526 Issue Date: 2024-09-23
- Contribution of extracellular vesicles to steatosis-related liver disease and their therapeutic potential
- Browse: 175 Download: 613 Issue Date: 2024-09-23
- Kick-start for metabolomics in liver disease
- Browse: 176 Download: 509 Issue Date: 2024-09-23
- Causal association between 731 immunocyte phenotypes and liver cirrhosis: A bidirectional two-sample mendelian randomization analysis
- Browse: 199 Download: 576 Issue Date: 2024-08-22
- Blood cell counts and nonalcoholic fatty liver disease: Evidence from Mendelian randomization analysis
- Browse: 265 Download: 624 Issue Date: 2024-08-22
- Successful treatment of acute liver failure due to Wilson’s disease: Serendipity or fortuity?
- Browse: 289 Download: 545 Issue Date: 2024-08-22
- Bridging the gap: Addressing disparities in hepatitis C screening, access to care, and treatment outcomes
- Browse: 215 Download: 434 Issue Date: 2024-08-22
- Rocahepevirus ratti: An underrecognised cause of acute hepatitis
- Browse: 173 Download: 456 Issue Date: 2024-08-22
- Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years
- Browse: 316 Download: 720 Issue Date: 2024-07-26
- Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis
- Browse: 322 Download: 811 Issue Date: 2024-07-26
- Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction
- Browse: 310 Download: 623 Issue Date: 2024-07-26
- Interleukin-mediated therapies in liver diseases and comorbidity effects
- Browse: 314 Download: 688 Issue Date: 2024-07-26
- Roles of transforming growth factor-β signaling in liver disease
- Browse: 348 Download: 608 Issue Date: 2024-07-26
- Successful treatment of severe hepatic impairment in erythropoietic protoporphyria: A case report and review of literature
- Browse: 272 Download: 713 Issue Date: 2024-06-27
- Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase
- Browse: 221 Download: 892 Issue Date: 2024-06-27
- Importance of the gut microbiota in the gut-liver axis in normal and liver disease
- Browse: 208 Download: 552 Issue Date: 2024-06-27
- Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both
- Browse: 202 Download: 510 Issue Date: 2024-06-27